Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer

Of patients with LABCC, those with non-SCC tumors ≥8 cm in size were at high risk for early central-only recurrence after cisplatin-based chemoradiation, and represent the subset of patients for whom AHR is beneficial.